BTMD
Healthcarebiote Corp.
$2.47
+$0.00 (+0.00%)
Jan 5, 2026
Price History (1Y)
Analysis
biote Corp. is a healthcare company in the medical care facilities industry with a market capitalization of $118.19M and 217 employees. The company's financial health indicates that it has achieved profitability, with gross margin at 72.4%, operating margin at 18.1%, and profit margin at 14.7%. The return on assets (ROA) stands at 21.9%. On the balance sheet side, biote Corp. has $106.41M in debt and $28.05M in cash. biote Corp.'s valuation context shows a P/E ratio of 3.13 with a forward P/E of 2.98, indicating a relatively low price to earnings multiple. The company's revenue growth has been negative at -6.7% year-over-year, while its earnings growth has also been declining at -33.3%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About biote Corp.
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Visit website →Key Statistics
- Market Cap
- $118.19M
- P/E Ratio
- 3.13
- 52-Week High
- $6.12
- 52-Week Low
- $2.31
- Avg Volume
- 126.41K
- Beta
- 1.16
Company Info
- Industry
- Medical Care Facilities
- Exchange
- NGM
- Country
- United States
- Employees
- 217